Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten T Bauer

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|July 26, 2012
Influenza A viruses target type II pneumocytes in the human lungViola K Weinheimer, Anne Becher, Mario Tönnies, et al.
Plos One|August 29, 2015
Serotype 1 and 8 Pneumococci Evade Sensing by Inflammasomes in Human Lung TissueDiana Fatykhova, Anne Rabes, Christoph Machnik, et al.
The European Respiratory Journal|March 24, 2012
Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissueKolja V Szymanski, Mario Toennies, Anne Becher, et al.
Scientific Reports|January 11, 2018
Pneumolysin induced mitochondrial dysfunction leads to release of mitochondrial DNAAndreas Nerlich, Maren Mieth, Eleftheria Letsiou, et al.
The European Respiratory Journal|November 6, 2020
Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failureLaura Michalick, Sarah Weidenfeld, Benjamin Grimmer, et al.
The Journal of Infection|March 14, 2026
Clade 2.3.4.4b H5N1 influenza A virus exhibits high infectivity in human respiratory tract modelsAnna Löwa, Matthias Budt, Anita Balázs, et al.
Critical Care Medicine|January 4, 2018
Sphingosine Kinase 1 Regulates Inflammation and Contributes to Acute Lung Injury in Pneumococcal Pneumonia via the Sphingosine-1-Phosphate Receptor 2Birgitt Gutbier, Stefanie M Schönrock, Carolin Ehrler, et al.
Deutsches Arzteblatt International|October 18, 2013
Adult patients with nosocomial pneumonia: epidemiology, diagnosis, and treatmentKlaus Dalhoff, Santiago Ewig, , et al.
The European Respiratory Journal|September 4, 2024
Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolusDiana Fatykhova, Verena N Fritsch, Keerthana Siebert, et al.
The Lancet. Infectious Diseases|April 30, 2013
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studiesWilhelmina G Melsen, Maroeska M Rovers, Rolf H H Groenwold, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|July 26, 2012
Influenza A viruses target type II pneumocytes in the human lungViola K Weinheimer, Anne Becher, Mario Tönnies, et al.
Plos One|August 29, 2015
Serotype 1 and 8 Pneumococci Evade Sensing by Inflammasomes in Human Lung TissueDiana Fatykhova, Anne Rabes, Christoph Machnik, et al.
The European Respiratory Journal|March 24, 2012
Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissueKolja V Szymanski, Mario Toennies, Anne Becher, et al.
Scientific Reports|January 11, 2018
Pneumolysin induced mitochondrial dysfunction leads to release of mitochondrial DNAAndreas Nerlich, Maren Mieth, Eleftheria Letsiou, et al.
The European Respiratory Journal|November 6, 2020
Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failureLaura Michalick, Sarah Weidenfeld, Benjamin Grimmer, et al.
The Journal of Infection|March 14, 2026
Clade 2.3.4.4b H5N1 influenza A virus exhibits high infectivity in human respiratory tract modelsAnna Löwa, Matthias Budt, Anita Balázs, et al.
Critical Care Medicine|January 4, 2018
Sphingosine Kinase 1 Regulates Inflammation and Contributes to Acute Lung Injury in Pneumococcal Pneumonia via the Sphingosine-1-Phosphate Receptor 2Birgitt Gutbier, Stefanie M Schönrock, Carolin Ehrler, et al.
Deutsches Arzteblatt International|October 18, 2013
Adult patients with nosocomial pneumonia: epidemiology, diagnosis, and treatmentKlaus Dalhoff, Santiago Ewig, , et al.
The European Respiratory Journal|September 4, 2024
Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolusDiana Fatykhova, Verena N Fritsch, Keerthana Siebert, et al.
The Lancet. Infectious Diseases|April 30, 2013
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studiesWilhelmina G Melsen, Maroeska M Rovers, Rolf H H Groenwold, et al.
Pageof 8